NEUROPSYCHOLOGICAL TEST-PERFORMANCE AND AFFECT IN MYASTHENIA-GRAVIS

被引:25
作者
BARTEL, PR [1 ]
LOTZ, BP [1 ]
机构
[1] UNIV PRETORIA,DEPT NEUROL,PRETORIA 0002,SOUTH AFRICA
来源
ACTA NEUROLOGICA SCANDINAVICA | 1995年 / 91卷 / 04期
关键词
MYASTHENIA GRAVIS; COGNITION; AFFECT; ANXIETY; NEUROPSYCHOLOGICAL PERFORMANCE;
D O I
10.1111/j.1600-0404.1995.tb07002.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuropsychological test performance, including memory, and affect were investigated in 16 patients with myasthenia gravis (MG) and in a matched control group. Clinical electroencephalograms (EEGs) were recorded from MG patients. Cognitive measures included the Randt Memory Test and a number of tests from the computerized Neurobehavioral Evaluation Battery which included a test of motor speed. Affect was assessed by means of an anxiety questionnaire (IPAT) and a computer based questionnaire similar to the Profile of Mood States (POMS). There were no significant intergroup differences in memory performance and only an isolated significant finding in a timed measure in symbol-digit comparison. The MG group revealed significantly reduced finger tapping. Significantly higher levels of anxiety, tension, anger, fatigue and confusion were associated with the MG group. Abnormal EEGs occurred in 35% of the MG patients, mostly mild-moderate diffuse slowing, but in one case epileptogenic activity was present. The failure to confirm memory deficits in this study appeared not to be related to age or whether patients had generalized or ocular MG. Medication was suggested as a possible factor. These, and other variables, need to be evaluated in further studies.
引用
收藏
页码:266 / 270
页数:5
相关论文
共 18 条
[1]
RECOVERY FROM GLOBAL AMNESIA DURING PLASMA-EXCHANGE IN MYASTHENIA-GRAVIS - REPORT OF A CASE [J].
AARLI, JA ;
GILHUS, NE ;
THORLACIUS, S ;
JOHNSEN, HJ .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 (04) :351-353
[2]
[Anonymous], 1971, MANUAL PROFILES MOOD
[3]
STUDIES ON THE POSSIBLE CENTRAL AND PERIPHERAL EFFECTS IN MAN OF A CHOLINESTERASE INHIBITOR (PYRIDOSTIGMINE) [J].
BORLAND, RG ;
BRENNAN, DH ;
NICHOLSON, AN ;
SMITH, PA .
HUMAN TOXICOLOGY, 1985, 4 (03) :293-300
[4]
CATTELL RB, 1968, MANUAL IPAT ANXIETY, P1
[5]
DAVIDOVLUSTIG M, 1992, AUTOIMMUNITY, V14, P85
[6]
PSYCHOMOTOR FUNCTION AND PSYCHOACTIVE-DRUGS [J].
HINDMARCH, I .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 10 (03) :189-209
[7]
HOKKANEN E, 1969, ACTA NEUROL SCAND, V45, P556
[8]
NEUROPSYCHOLOGICAL FUNCTION BEFORE AND AFTER PLASMA-EXCHANGE IN MYASTHENIA-GRAVIS [J].
IWASAKI, Y ;
KINOSHITA, M ;
IKEDA, K ;
SHIOJIMA, T ;
KURIHARA, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 114 (02) :223-226
[9]
COGNITION IN MYASTHENIA [J].
IWASAKI, Y ;
KINOSHITA, M ;
IKEDA, K ;
TAKAMIYA, K .
NEUROLOGY, 1989, 39 (07) :1002-1002
[10]
LETZ R, 1988, NES2 NEUROBEHAVIORAL, P20